Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
82
NCT02728492
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2013
Completion: Jan 31, 2016
NCT02948075
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
Phase: Phase 2
Start: Sep 30, 2015
Completion: Jun 16, 2017